相似文献
1
Europe needs a central, transparent, and evidence-based approval process for behavioural prevention interventions.
PLoS Med. 2014 Oct 7;11(10):e1001740. doi: 10.1371/journal.pmed.1001740. eCollection 2014 Oct.
2
A new approach to psychiatric drug approval in Europe.
PLoS Med. 2013 Oct;10(10):e1001530. doi: 10.1371/journal.pmed.1001530. Epub 2013 Oct 15.
3
Optimal evidence in difficult settings: improving health interventions and decision making in disasters.
PLoS Med. 2014 Apr 22;11(4):e1001632. doi: 10.1371/journal.pmed.1001632. eCollection 2014 Apr.
4
Configuring balanced scorecards for measuring health system performance: evidence from 5 years' evaluation in Afghanistan.
PLoS Med. 2011 Jul;8(7):e1001066. doi: 10.1371/journal.pmed.1001066. Epub 2011 Jul 26.
5
Modelling the strategic use of antiretroviral therapy for the treatment and prevention of HIV.
PLoS Med. 2013 Oct;10(10):e1001535. doi: 10.1371/journal.pmed.1001535. Epub 2013 Oct 22.
6
The shortcomings of science at the point of care delivery: An editors' retrospective.
Fam Syst Health. 2024 Dec;42(4):485-492. doi: 10.1037/fsh0000947.
7
Readers' and editors' responses: "American healthcare is the best in the world if...".
MedGenMed. 2004 Sep 24;6(3):27.
8
The prevention of postpartum hemorrhage in the community.
PLoS Med. 2013 Oct;10(10):e1001525. doi: 10.1371/journal.pmed.1001525. Epub 2013 Oct 1.
9
Guest editors' introduction.
Health Econ. 2007 Sep;16(9):871-3. doi: 10.1002/hec.1257.
10
Saving lives in health: global estimates and country measurement.
PLoS Med. 2013 Oct;10(10):e1001523. doi: 10.1371/journal.pmed.1001523. Epub 2013 Oct 1.
引用本文的文献
1
Evaluator's alignment as an important indicator of adequacy of the criteria and assessment procedure for recognizing the good practice in public health.
Front Public Health. 2024 Apr 22;12:1286509. doi: 10.3389/fpubh.2024.1286509. eCollection 2024.
2
Health promotion and disease prevention registries in the EU: a cross country comparison.
Arch Public Health. 2023 May 10;81(1):85. doi: 10.1186/s13690-023-01097-0.
3
Normalization of Prevention Principles and Practices to Reduce Substance Use Disorders Through an Integrated Dissemination and Implementation Framework.
Prev Sci. 2023 Aug;24(6):1078-1090. doi: 10.1007/s11121-023-01532-2. Epub 2023 Apr 13.
4
Transparent, Open, and Reproducible Prevention Science.
Prev Sci. 2022 Jul;23(5):701-722. doi: 10.1007/s11121-022-01336-w. Epub 2022 Feb 17.
5
Evaluating the Effectiveness of Gamification on Physical Activity: Systematic Review and Meta-analysis of Randomized Controlled Trials.
J Med Internet Res. 2022 Jan 4;24(1):e26779. doi: 10.2196/26779.
6
Short-Term Effectiveness of the Youth Gambling Prevention Program "Who Really Wins?"-Results from the First National Implementation.
Int J Environ Res Public Health. 2021 Sep 26;18(19):10100. doi: 10.3390/ijerph181910100.
7
Social Psychological Correlates of Protective Behaviours in the COVID-19 Outbreak: Evidence and Recommendations from a Nationally Representative Sample.
Appl Psychol Health Well Being. 2020 Dec;12(4):1183-1204. doi: 10.1111/aphw.12235. Epub 2020 Sep 27.
8
A School-Based Program to Promote Well-Being in Preadolescents: Results From a Cluster Quasi-Experimental Controlled Study.
J Prim Prev. 2019 Apr;40(2):151-170. doi: 10.1007/s10935-018-0530-y.
9
Improving health promotion through central rating of interventions: the need for Responsive Guidance.
Health Res Policy Syst. 2017 Nov 23;15(1):100. doi: 10.1186/s12961-017-0258-9.
10
Reframing the science and policy of nicotine, illegal drugs and alcohol - conclusions of the ALICE RAP Project.
F1000Res. 2017 Mar 17;6:289. doi: 10.12688/f1000research.10860.1. eCollection 2017.
本文引用的文献
1
We need access to data on all clinical trials, not just some.
BMJ. 2012 Nov 26;345:e8001. doi: 10.1136/bmj.e8001.
2
Interventions for preventing obesity in children.
Cochrane Database Syst Rev. 2011 Dec 7(12):CD001871. doi: 10.1002/14651858.CD001871.pub3.
3
Universal multi-component prevention programs for alcohol misuse in young people.
Cochrane Database Syst Rev. 2011 Sep 7(9):CD009307. doi: 10.1002/14651858.CD009307.
4
UN High-Level Meeting on Non-Communicable Diseases: addressing four questions.
Lancet. 2011 Jul 30;378(9789):449-55. doi: 10.1016/S0140-6736(11)60879-9. Epub 2011 Jun 12.
5
The behaviour change wheel: a new method for characterising and designing behaviour change interventions.
Implement Sci. 2011 Apr 23;6:42. doi: 10.1186/1748-5908-6-42.
6
Priority actions for the non-communicable disease crisis.
Lancet. 2011 Apr 23;377(9775):1438-47. doi: 10.1016/S0140-6736(11)60393-0. Epub 2011 Apr 5.
7
The multiphase optimization strategy for engineering effective tobacco use interventions.
Ann Behav Med. 2011 Apr;41(2):208-26. doi: 10.1007/s12160-010-9253-x.
8
Towards evidence-based, quality-controlled health promotion: the Dutch recognition system for health promotion interventions.
Health Educ Res. 2010 Dec;25(6):1100-6. doi: 10.1093/her/cyq046. Epub 2010 Sep 13.
9
Specifying and reporting complex behaviour change interventions: the need for a scientific method.
Implement Sci. 2009 Jul 16;4:40. doi: 10.1186/1748-5908-4-40.
10
The Adolescent Substance Abuse Prevention Study: A randomized field trial of a universal substance abuse prevention program.
Drug Alcohol Depend. 2009 Jun 1;102(1-3):1-10. doi: 10.1016/j.drugalcdep.2009.01.015. Epub 2009 Mar 29.
Zotero 插件